HUTCHMED to Announce 2024 Final Results
HUTCHMED (Nasdaq/AIM: HCM; SEHK:13) has scheduled the announcement of its 2024 final results for Wednesday, March 19, 2025, at 7:00 am EDT / 11:00 am GMT / 7:00 pm HKT. The company will host two conference calls with audio webcasts: an English presentation at 8:00 am EDT on March 19, and a Chinese (Putonghua) presentation at 8:30 pm EDT on the same day.
The presentation materials will be available for download before the conference calls on the company's website. Both webcasts can be accessed at www.hutch-med.com/event/, and a replay will be made available after the events.
HUTCHMED (Nasdaq/AIM: HCM; SEHK:13) ha programmato l'annuncio dei suoi risultati finali 2024 per mercoledì 19 marzo 2025, alle 7:00 EDT / 11:00 GMT / 19:00 HKT. L'azienda ospiterà due conference call con webcast audio: una presentazione in inglese alle 8:00 EDT del 19 marzo e una presentazione in cinese (Putonghua) alle 20:30 EDT dello stesso giorno.
Il materiale della presentazione sarà disponibile per il download prima delle conference call sul sito web dell'azienda. Entrambi i webcast possono essere accessibili su www.hutch-med.com/event/, e una registrazione sarà resa disponibile dopo gli eventi.
HUTCHMED (Nasdaq/AIM: HCM; SEHK:13) ha programado el anuncio de sus resultados finales de 2024 para el miércoles 19 de marzo de 2025, a las 7:00 am EDT / 11:00 am GMT / 7:00 pm HKT. La empresa llevará a cabo dos conferencias telefónicas con transmisiones de audio: una presentación en inglés a las 8:00 am EDT del 19 de marzo y una presentación en chino (Putonghua) a las 8:30 pm EDT del mismo día.
Los materiales de la presentación estarán disponibles para su descarga antes de las conferencias telefónicas en el sitio web de la empresa. Ambas transmisiones se pueden acceder en www.hutch-med.com/event/, y se hará disponible una repetición después de los eventos.
HUTCHMED (Nasdaq/AIM: HCM; SEHK:13)은 2025년 3월 19일 수요일 오전 7시 EDT / 오후 11시 GMT / 오후 7시 HKT에 2024년 최종 결과 발표를 예정하고 있습니다. 회사는 두 차례의 오디오 웹캐스트가 포함된 컨퍼런스 콜을 진행할 예정이며, 3월 19일 오전 8시에 영어 발표가, 같은 날 오후 8시 30분에 중국어(보통화) 발표가 진행됩니다.
발표 자료는 컨퍼런스 콜 전에 회사 웹사이트에서 다운로드할 수 있습니다. 두 웹캐스트는 www.hutch-med.com/event/에서 접근할 수 있으며, 이벤트 후에 재생이 제공될 것입니다.
HUTCHMED (Nasdaq/AIM: HCM; SEHK:13) a prévu l'annonce de ses résultats finaux 2024 pour le mercredi 19 mars 2025, à 7h00 EDT / 11h00 GMT / 19h00 HKT. L'entreprise organisera deux conférences téléphoniques avec des webcasts audio : une présentation en anglais à 8h00 EDT le 19 mars et une présentation en chinois (Putonghua) à 20h30 EDT le même jour.
Les documents de présentation seront disponibles en téléchargement avant les conférences téléphoniques sur le site web de l'entreprise. Les deux webcasts peuvent être consultés sur www.hutch-med.com/event/, et une rediffusion sera disponible après les événements.
HUTCHMED (Nasdaq/AIM: HCM; SEHK:13) hat die Bekanntgabe seiner Jahresergebnisse 2024 für Mittwoch, den 19. März 2025, um 7:00 Uhr EDT / 11:00 Uhr GMT / 19:00 Uhr HKT angesetzt. Das Unternehmen wird zwei Telefonkonferenzen mit Audio-Webcasts veranstalten: eine Präsentation auf Englisch um 8:00 Uhr EDT am 19. März und eine Präsentation auf Chinesisch (Putonghua) um 20:30 Uhr EDT am selben Tag.
Die Präsentationsmaterialien werden vor den Telefonkonferenzen auf der Unternehmenswebsite zum Download zur Verfügung stehen. Beide Webcasts sind unter www.hutch-med.com/event/ erreichbar, und eine Wiederholung wird nach den Veranstaltungen bereitgestellt.
- None.
- None.
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December 31, 2024 on Wednesday, March 19, 2025 at 7:00 am Eastern Daylight Time (EDT) / 11:00 am Greenwich Mean Time (GMT) / 7:00 pm Hong Kong Time (HKT).
Analysts and investors are invited to join a conference call and audio webcast presentation with Q&A, conducted by HUTCHMED management.
The English conference call and audio webcast will take place at 8:00 am EDT / 12:00 pm GMT / 8:00 pm HKT on Wednesday, March 19, 2025. In addition to the usual English webcast, there will also be a Chinese (Putonghua) webcast at 12:30 am GMT / 8:30 am HKT on Thursday, March 20, 2025 (8:30 pm EDT on Wednesday, March 19, 2025). Both webcasts will be available live via the company website at www.hutch-med.com/event/. The presentation will be available for downloading before the conference call begins. Details of the conference call dial-in will be provided in the financial results announcement and on the company website. A replay will also be available on the website shortly after the event.
About HUTCHMED
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Since inception, HUTCHMED has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three medicines marketed in China, the first of which is also approved in the US, Europe and Japan. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.
CONTACTS
| Investor Enquiries | +852 2121 8200 / ir@hutch-med.com |
| Media Enquiries | |
| FTI Consulting – | +44 20 3727 1030 / HUTCHMED@fticonsulting.com |
| Ben Atwell / Alex Shaw | +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile) |
| Brunswick – Zhou Yi | +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com |
| Panmure Liberum | Nominated Advisor and Joint Broker |
| Atholl Tweedie / Freddy Crossley / Rupert Dearden | +44 20 7886 2500 |
| HSBC | Joint Broker |
| Simon Alexander / Alina Vaskina / Arnav Kapoor | +44 20 7991 8888 |
| Cavendish | Joint Broker |
| Geoff Nash / Nigel Birks | +44 20 7220 0500 |
FAQ
When will HUTCHMED (HCM) release its 2024 annual financial results?
What time is HUTCHMED's (HCM) English earnings call for 2024 results?
When is HUTCHMED's (HCM) Chinese language earnings call scheduled?
Where can I access HUTCHMED's (HCM) 2024 earnings presentation materials?
